BioHarvest Sciences Financials - Benzinga

BioHarvest Sciences Inc

BHSTNASDAQ

Trade with Public

Trade with Public

$1.84

-0.01-0.54%

At close: Aug 28, 5:00 PM EST

$1.84

N/A

After Hours: Aug 28, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

BioHarvest Sciences Financials

BioHarvest Sciences (BHST) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Conference Call: BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est

BioHarvest Sciences (NASDAQ:BHST) lowers FY2026 sales outlook from $42.000 million-$48.000 million to $37.000 million-$40.000 million vs $42.914 million estimate.

Benzinga Newsdesk

PRO
BioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M

BioHarvest Sciences (NASDAQ:BHST) stated that full-year 2026 revenue guidance for its CDMO business has been narrowed to $4 million-$5 million, from $4 million-$6 million previously, while revenue guidance for the VINIA

Benzinga Newsdesk

PRO
BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.17) Misses $(0.12) Estimate, Sales $8.837M Miss $9.537M Estimate

Benzinga Newsdesk

PRO
BioHarvest Sciences Affirms FY2026 Sales Guidance of $42.000M-$48.000M vs $44.721M Est

BioHarvest Sciences (NASDAQ:BHST) affirms FY2026 sales outlook from $42.000 million-$48.000 million to $42.000 million-$48.000 million vs $44.721 million estimate.

Benzinga Newsdesk

PRO
BioHarvest Sciences Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $8.500M Miss $8.796M Estimate

BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 15.38 percent increase over losses of

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights